Today we will open a special session on Desci to see if there are any good projects in it. A few days ago, we looked at the pumpscienc project and learned about the initial concept of Desci. In fact, this concept is quite good. Let’s first popularize the concept of Desci.
DeSci's Core Philosophy
Open Science: Lower the threshold for access to scientific research results, allowing more people to participate equally in scientific discussions and research.
Decentralization: Research results are recorded through blockchain technology to prevent tampering and ensure the integrity and credibility of data.
Knowledge sharing and fair distribution: Using smart contracts and token economic models to reward researchers and contributors and avoid intellectual property monopoly.
Community-driven: Rely on decentralized community power to advance scientific projects, rather than relying solely on large institutions or government funding.
In fact, the Desci concept research organization Messari released it in May of 2023. As shown in the figure below, we will select some to talk about.
3.BIO -Desci DAO Incubator
BIO is a content curation and liquidity protocol focused on decentralized science (DeSci), dedicated to accelerating the development of biotechnology. BIO aims to empower patients, scientists and biotechnology professionals around the world, enabling them to jointly fund, build and own biotechnology projects and intellectual property (IP) in tokenized form.
BIO's core team has been involved in the creation of Molecule (a tokenized platform for early biomedicine) and VitaDAO (currently the largest decentralized community for longevity science). Building on these successes, BIO is committed to promoting the thriving on-chain scientific economy through decentralized funding, incentive mechanisms, and liquidity.
To apply for the BioDAO launch, interested individuals will need to submit an application, which will be fully reviewed. Successfully selected applicants will receive the first tranche of funding based on their achievement of milestones required for the BioDAO launch. Non-DAO participants can also participate in the live auction, ensure sufficient balance in their wallet, place bids, monitor the progress of the auction, and claim token allocations.
On November 6, Binance Labs announced an investment in BIO Protocol (BIO) to accelerate the funding innovation of decentralized science (DeSci), hoping to use blockchain technology to promote solutions to rare diseases, longevity research, and emerging health, which are currently difficult to overcome. The BIO Protocol network currently has seven BIO DAOs, covering cryopreservation, women's health, mental health and other areas. The protocol token BIO and the tokens of its partner DAOs can be used as targets of attention.
Successful incubation cases:
VitaDAO: $5M+ in funding for longevity science, backed by Pfizer Ventures and in partnership with Newcastle University.
HairDAO: Targets hair loss; DAO owns patent and consumer product Follicool.
CerebrumDAO: Advancing brain health, raised over $1.5 million, inked a deal with Fission Pharma to address mitochondrial dysfunction in neurodegenerative diseases.
ValleyDAO: Focused on synthetic biology, it has raised over $2 million and is working with Imperial College London.
AthenaDAO: Advancing women’s health R&D, providing $500,000 in funding for translational research, with 14 intellectual property deals currently pending.
CryoDAO: Advancing the field of cryogenics, raising over $3 million for the field and establishing projects with Oxford Cryogenics and Advanced Neurobiosciences.
PsyDAO: Focused on psychedelic drugs, it launched OPSY, a new platform that leverages psychedelic drug trials and data.
BIO second group early admission list:
Long COVID Labs: Accelerating the cure of more than 100 million Long COVID patients. Founded by Rohan Dixit, a former Stanford University neuroscientist, healthcare entrepreneur and Long COVID survivor.
Quantum Biology DAO: Developing quantum microscopes to advance biological research. Founded by Clarice D. Aiello, MIT PhD and world-leading quantum biology scientist, and Geoff Anders, Executive Director of Leverage Research.
Curetopia (Rare Diseases): Addressing the $1 trillion+ rare disease space by uniting families and patient communities. Founded by Harvard PhD, entrepreneur, and Y-Combinator alumnus Ethan Perlstein.
Core Process
To achieve these goals, the BIO protocol has 5 core operations:
1. Screening (Curation | BIO Staking)
BIO token holders participate in the screening of which new BioDAOs can join the ecosystem. In order to ensure that the BIO protocol can absorb high-quality BioDAOs, the screening requires locking BIO tokens (vBIO) to participate, thereby ensuring that participants are aligned with the long-term goals of the network.
2. Funding
If a BioDAO applicant is accepted into the BIO Network, all vBIO stakers backing that BioDAO will be able to participate in the initial private auction, the whitelisted seed round.
3. Liquidity
The focus of BioDAOs should be on scientific research rather than managing liquidity. The BIO Protocol reduces the burden on BioDAOs by managing their liquidity issues in the secondary market.
4.Bio/acc Rewards
The BIO Protocol can incentivize BioDAOs to achieve specific key goals through rewards in the form of BIO tokens (called “bio/acc rewards”), thereby increasing the value of the network (such as assets under management, AUM).
5. Meta-Governance
The BIO Protocol will hold multiple BioDAO tokens, enabling it to serve as a meta-governance layer, empowering BIO token holders to participate in the governance of multiple BioDAOs and scientific IP assets.
Token Data
On August 9, BIO Protocol launched the first round of Bio Genesis token sales, with an average price of $0.025 and a trading volume of $11.51 million. The second round of token sales was held on September 30, and the average price of BIO has increased by 72% to $0.043, and the trading volume has also increased to $19.49 million. Until the 2.5th round of public auction on November 10, the price of BIO rose to $0.066, an increase of 264% from the first round. At present, the auction round of BIO Protocol has ended.
Token Allocation
BIO Network is providing a $100,000 grant to the incubated BioDAO in exchange for 6.9% of the BioDAO token supply.
BIO tokens can be used for the following purposes:
-Invite BioDAO to join the BIO Protocol Program
- Priority participation in BioDAO token sale and IP token sale
-BioDAO health product/service discounts
-Meta-Governance in BioDAO
-Vote on BIO issuance, funding allocation, and protocol updates
Airdrop
-3% of BIO supply airdrop
->8,500 addresses meet the criteria
-Airdrop snapshot taken on April 1, 2024
- Users receive vBIO (vested BIO) and can immediately redeem it for $BIO
-$BIO tokens are non-transferable until unlocked by a governance vote.
To conclude, at present, this BIO still has a future. The so-called private placement stage should be over, and it has received investment from Binance. It should be listed in the future, which can almost be said to be a surge, so we should pay attention to its next round. Previously, it was introduced that it has 2 rounds and 3 project lists, which may be opened in the future. We will continue to introduce the situation of these projects later, so please stay tuned.
